- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neurobo Pharmaceuticals Inc (NRBO)
NASDAQ
Currency in USD
Disclaimer
2.5500
+0.0800(+3.24%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.4100
2.5801
52 wk Range
2.0800
6.7499
NRBO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Neurobo Pharmaceuticals Inc stock price live, this page displays NASDAQ NRBO stock exchange data. View the NRBO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neurobo Pharmaceuticals Inc real time stock price chart below.
What Is the Neurobo Pharmaceuticals Inc Stock Price Today?
The Neurobo Pharmaceuticals Inc stock price today is 2.5500.
What Is the Stock Symbol for Neurobo Pharmaceuticals Inc?
The stock ticker symbol for Neurobo Pharmaceuticals Inc is NRBO.
Is NRBO the Same as $NRBO?
$NRBO is a common way to refer to the Neurobo Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Neurobo Pharmaceuticals Inc Trade On?
Neurobo Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Neurobo Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Neurobo Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Neurobo Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRBO quote. (ISIN: US64132R4048)
What Is the Neurobo Pharmaceuticals Inc Stock Price Today?
The Neurobo Pharmaceuticals Inc stock price today is 2.5500.
What Is the Stock Symbol for Neurobo Pharmaceuticals Inc?
The stock ticker symbol for Neurobo Pharmaceuticals Inc is NRBO.
Is NRBO the Same as $NRBO?
$NRBO is a common way to refer to the Neurobo Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Neurobo Pharmaceuticals Inc Trade On?
Neurobo Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Neurobo Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Neurobo Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Neurobo Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRBO quote. (ISIN: US64132R4048)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.41002.5801
52 wk Range
2.08006.7499
UnlockNRBO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
26.6667
Upside
+945.7529%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Neurobo Pharmaceuticals Inc Company Profile
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company’s therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and joint research agreement with Dong-A ST and ImmunoForge for the development of DA-1726. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Compare NRBO to Peers and Sector
Metrics to compare | NRBO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNRBOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.3x | −0.6x | |
PEG Ratio | 0.03 | 0.00 | 0.00 | |
Price / Book | 1.1x | 2.5x | 2.6x | |
Price / LTM Sales | - | 36.2x | 3.2x | |
Upside (Analyst Target) | - | 185.7% | 48.5% | |
Fair Value Upside | Unlock | 10.5% | 7.8% | Unlock |
People Also Watch
FAQ
What Is the Neurobo Pharmaceuticals (NRBO) Stock Price Today?
The Neurobo Pharmaceuticals stock price today is 2.55
What Stock Exchange Does Neurobo Pharmaceuticals Trade On?
Neurobo Pharmaceuticals is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Neurobo Pharmaceuticals?
The stock symbol for Neurobo Pharmaceuticals is "NRBO."
What Is the Neurobo Pharmaceuticals Market Cap?
As of today, Neurobo Pharmaceuticals market cap is 21.30M.
What is Neurobo Pharmaceuticals Earnings Per Share?
The Neurobo Pharmaceuticals EPS is -5.01.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.